Who owns Citius Pharmaceuticals Inc?
- Ticker: CTXR
- CUSIP Number: 17322u207
Tip: Access positions for across all investors
Analyze quarterly positions in Citius Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Citius Pharmaceuticals stock
Who bought or sold Citius Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 8.7M | $7.8M | 12% | Mar 2024 |
|
| Vanguard Group | 7.0M | $6.3M | 2% | Mar 2024 |
|
| Geode Capital Management | 2.9M | $2.6M | 10% | Mar 2024 |
|
| Northern Trust | 1.1M | $1.0M | 6% | Mar 2024 |
|
| Advisor Group Holdings | 932k | $839k | 0% | Mar 2024 |
|
| Nuveen Asset Management | 485k | $435k | 0% | Mar 2024 |
|
| Charles Schwab Investment Management | 357k | $320k | 0% | Mar 2024 |
|
| Bank of New York Mellon | 320k | $288k | -6% | Mar 2024 |
|
| HighTower Advisors | 210k | $188k | 3% | Mar 2024 |
|
| Morgan Stanley | 192k | $172k | 152% | Mar 2024 |
|
| Inspire Advisors | 157k | $141k | -14% | Mar 2024 |
|
| Rhumbline Advisers | 157k | $141k | 4% | Mar 2024 |
|
| Wealth Advisory Solutions | 151k | $136k | 100% | Mar 2024 |
|
| UBS Group | 135k | $121k | -2% | Mar 2024 |
|
| Arkadios Wealth Advisors | 100k | $90k | -81% | Mar 2024 |
|
| William Blair $ Company | 96k | $86k | 5% | Mar 2024 |
|
| Barclays | 95k | $85k | -44% | Mar 2024 |
|
| Goldman Sachs Group | 88k | $79k | -5% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 86k | $78k | 0% | Mar 2024 |
|
| Chelsea Counsel | 81k | $62k | 0% | Dec 2023 |
|
| Jane Street | 78k | $70k | -21% | Mar 2024 |
|
| New York State Common Retirement Fund | 78k | $70k | 0% | Mar 2024 |
|
| XTX Topco | 78k | $70k | 167% | Mar 2024 |
|
| Horst & Graben Wealth Management | 76k | $68k | 0% | Mar 2024 |
|
| Kestra Advisory Services | 72k | $55k | -21% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 70k | $63k | 89% | Mar 2024 |
|
| American International | 61k | $46k | 0% | Dec 2023 |
|
| LPL Financial | 59k | $53k | 100% | Mar 2024 |
|
| Bank of America Corporation | 52k | $47k | -71% | Mar 2024 |
|
| Jpmorgan Chase & Co | 51k | $46k | -36% | Mar 2024 |
|
| Wells Fargo & Company | 51k | $46k | 23% | Mar 2024 |
|
| Miller Investment Management | 50k | $38k | 0% | Dec 2023 |
|
| Ing Investment Management | 48k | $43k | -8% | Mar 2024 |
|
| SG Americas Securities | 41k | $37k | -35% | Mar 2024 |
|
| Private Advisor | 40k | $36k | 0% | Mar 2024 |
|
| T. Rowe Price Associates | 30k | $28k | 7% | Mar 2024 |
|
| TCG Advisory Services | 30k | $27k | 0% | Mar 2024 |
|
| Citigroup | 25k | $22k | 41% | Mar 2024 |
|
| ProShare Advisors | 24k | $22k | 51% | Mar 2024 |
|
| Group One Trading | 20k | $18k | -24% | Mar 2024 |
|
| Victory Capital Management | 19k | $17k | -2% | Mar 2024 |
|
| FMR | 18k | $16k | 603% | Mar 2024 |
|
| Principal Financial Group | 16k | $14k | -9% | Mar 2024 |
|
| Csenge Advisory Group | 15k | $14k | 0% | Mar 2024 |
|
| Franklin Resources | 14k | $13k | 0% | Mar 2024 |
|
| California State Teachers Retirement System | 14k | $12k | -50% | Mar 2024 |
|
| Legal & General Group | 12k | $10k | 0% | Mar 2024 |
|
| Alliancebernstein | 11k | $8.5k | 0% | Dec 2023 |
|
| Susquehanna International | 11k | $10k | -77% | Mar 2024 |
|
| Raymond James Financial Services Advisors | 11k | $10k | 0% | Mar 2024 |
|
| Shared Vision Wealth Group | 11k | $9.6k | 0% | Mar 2024 |
|
| Summit Investment Advisors | 10k | $9.1k | 0% | Mar 2024 |
|
| Measured Wealth Private Client Group | 10k | $9.0k | 0% | Mar 2024 |
|
| Ethos Financial Group | 10k | $9.0k | 100% | Mar 2024 |
|
| Tower Research Capital | 8.2k | $7.3k | -50% | Mar 2024 |
|
| Simplex Trading | 7.2k | $6.0k | -83% | Mar 2024 |
|
| Amalgamated Bank | 4.1k | $4.0k | -64% | Mar 2024 |
|
| Princeton Global Asset Management | 4.0k | $3.6k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 3.0k | $0 | -92% | Mar 2024 |
|
| Ronald Blue Trust | 3.0k | $2.7k | 0% | Mar 2024 |
|
| Quent Capital | 2.8k | $2.5k | 0% | Mar 2024 |
|
| Aspire Private Capital | 300.00 | $269.010000 | 0% | Mar 2024 |
|
| Creative Financial Designs | 250.00 | $224.000000 | 100% | Mar 2024 |
|
| Pnc Financial Services | 177.00 | $158.999100 | 195% | Mar 2024 |
|
| Farther Finance Advisors | 80.00 | $82.000000 | 100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 18.00 | $16.000200 | 100% | Mar 2024 |
|
| CWM | 13.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Citius Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Dec 2023 | 52k | $39k |
| Florida State Board of Administration | Dec 2023 | 32k | $24k |
| Two Sigma Securities | Dec 2023 | 32k | $24k |
| Citadel Advisors | Dec 2023 | 28k | $21k |
| Williams Jones Wealth Management | Sep 2023 | 10k | $6.8k |
| Bourgeon Capital Management | Dec 2023 | 1.5k | $1.1k |
| Huntington National Bank | Dec 2023 | 1.5k | $1.1k |
| American National Bank | Dec 2023 | 1.0k | $757.000000 |
| Atlantic Edge Private Wealth Management | Dec 2023 | 1.0k | $757.000000 |
| Cutler | Dec 2023 | 521.00 | $0 |
| Focused Wealth Management | Dec 2023 | 270.00 | $204.012000 |